Latest Regulation News

Actinogen Medical’s pivotal XanaMIA trial clears a key interim hurdle with the Data Monitoring Committee endorsing continuation, while a $16.8 million capital raise and non-dilutive funding bolster its balance sheet ahead of final results due November 2026.

Argent BioPharma secured a 48% stake in CannPal Animal Therapeutics, shipped its largest CannEpil® order to Ireland worth A$783,000, and filed a US provisional patent for its NanoBodies platform, underpinning its neuro-immune strategy and commercial growth.

Thor Energy secured A$6.56 million from the Molyhil sale, expanded its natural hydrogen portfolio with new Otway Basin licences, and advanced its HY-Range Project geochemistry survey during Q1 2026.

Emyria Limited is extending its Empax mental health clinic network into New South Wales through a new partnership with Matilda Nepean Private Hospital, increasing treatment capacity and national reach ahead of a planned Q3 2026 launch.

Arafura Rare Earths has locked in binding cornerstone equity agreements worth approximately A$230 million, bolstering its path to a final investment decision for the Nolans Project. The company also acquired critical camp infrastructure and is progressing technology development and offtake negotiations amid supportive government frameworks.

EVE Health Group has begun commercial sales of Libbo, an oral dissolving film for erectile dysfunction, supported by a new digital men’s health platform. The company also expanded its pharmaceutical pipeline and secured $1.3 million in fresh capital to fund ongoing development and commercialization.

Acrux pivots from generics to developing a Female Testosterone therapy for HSDD, leveraging FDA feedback and a strong US market opportunity.

Stakk Ltd has reported a striking 186% quarter-on-quarter revenue jump to A$5.52 million in Q1 2026, driven by converting contracted clients into active billing and new engagements, underpinning strong recurring revenue and cash flow.

Algorae Pharmaceuticals has struck an exclusive commercial and licensing agreement with global pharma Zydus Lifesciences to bring 10 injectable, oral, and specialty medicines to Australia and New Zealand, pending regulatory approvals.

Way2VAT reported a 95% surge in Q1 FY26 revenue to $2.05 million, driven by its RBC acquisition and expanding client base, while preparing to launch an e-invoicing platform integrating AI-powered APAI technology.

TMK Energy’s Gurvantes XXXV project hit a new daily gas production record exceeding 1,350 m³, confirming commercial desorption. The company secured $6 million in funding and regulatory approval to drill three new pilot wells and advance domestic gas use in Mongolia.

Jade Gas Holdings has secured Mongolian regulator approval for its TTCBM Project appraisal report, paving the way for reserve booking and submission of a development plan toward Mongolia's first significant gas operation.